Skip to main content

Table 4 Number of toxicities associated with GFIP/BDC

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

Toxicity

None

Grade 1

Grade 2

Grade 3

Grade 4

Hematologic

3

1

11

4

1

Constitutional

7

2

8

2

0

Gastrointestinal

14

0

3

2

0

Nutrition

18

0

1

1

0

Neurologic

18

1

1

2

0

Pain

19

0

1

0

0

Vascular

19

0

0

1

0

General

19

0

1

0

0